News
The progression to a Phase IIb clinical study follows encouraging results from Exonate’s Phase Ib/IIa study in March 2024. In the study, lead candidate EXN407 met its primary safety and ...
GeniPhys, a preclinical-stage company developing regenerative biomaterials for soft tissue restoration, has been awarded a $500,000 NSF SBIR Phase IIB supplemental funding grant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback